To tell you everything at the editorial office Croblanc, we know all the interest that our community has on the Youtube channel of Bloomberg Television. With each new content, the interest is always bigger, whether it's on our website or even on social networks. Sometimes we hesitate to write an article because we don't know if you will like it, but today we know that this video will interest you.
When we first saw the Pfizer Buys Cancer-Drug Maker Seagen for $43 Billion video on the Bloomberg Television channel, we knew our community would want to stream it as soon as possible. So we wrote this article to publish it as soon as possible.
For several hours, many people have been talking about this new video on social networks and it also makes people react on many discussion forums. This is not the first time that the Youtube channel Bloomberg Television releases a video that makes people talk about it, and we know your great interest for this kind of content.
Sometimes when we watch a video on the internet, we can have some feedback to give to the content creator. To tell him about a problem or an error that we discovered for example. To get the email address of an influencer who makes videos on the internet, go to the "About" section of his Youtube channel. If despite your efforts, you don't get a response, try to reach him/her on another medium. Twitter is very convenient to contact youtubers easily.
You now have all the information about the video Pfizer Buys Cancer-Drug Maker Seagen for $43 Billion, we hope you like it and that you found it interesting. Find now other similar videos on our platform, we trust you to find other nuggets. If and only if you have already visited our site, then go to Youtube to see other exclusive contents of Bloomberg Television.
We'll see you soon for a new content on Croblanc, and in the meantime we say Ciao to the next one!
For your information, you can find below the description of the video Pfizer Buys Cancer-Drug Maker Seagen for $43 Billion published by the Youtube channel Bloomberg Television:
Pfizer Inc. is purchasing cancer-drug maker Seagen Inc. for an enterprise value of $43 billion, using the biggest deal of the year to set its course out of the pandemic and back into mainstream pharma. Pfizer CEO Dr. Albert Bourla speaks to David Westin.
Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com
Connect with us on...
Twitter: https://twitter.com/business
Facebook: https://www.facebook.com/bloombergbusiness/
Instagram: https://www.instagram.com/quicktake/?hl=en